MPXOF (MPX International) Accounts Payable & Accrued Expense: $7.74 Mil (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MPX International Accounts Payable & Accrued Expense?

MPX International MPXOF -99.00% Accounts Payable & Accrued Expense is $7.74 Mil as of Mar. 2022.

MPX International's quarterly accounts payable & accrued expense increased from Sep. 2021 ($5.96 Mil) to Dec. 2021 ($6.30 Mil) and increased from Dec. 2021 ($6.30 Mil) to Mar. 2022 ($7.74 Mil).

MPX International's annual accounts payable & accrued expense increased from Sep. 2019 ($3.15 Mil) to Sep. 2020 ($4.81 Mil) and increased from Sep. 2020 ($4.81 Mil) to Sep. 2021 ($5.96 Mil).

MPX International Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for MPX International's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPX International Accounts Payable & Accrued Expense Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Accounts Payable & Accrued Expense
0.11 3.15 4.81 5.96

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.35 4.89 5.96 6.30 7.74

MPX International Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $7.74 Mil mean?
MPX International (MPXOF) has a Accounts Payable & Accrued Expense of $7.74 Mil as of Mar. 2022. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on MPX International and its competitors.
Is MPX International's Accounts Payable & Accrued Expense too high?
MPX International's current Accounts Payable & Accrued Expense is $7.74 Mil.
How does MPX International's Accounts Payable & Accrued Expense compare to ZTS and CTLT?
MPX International's Accounts Payable & Accrued Expense of $7.74 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Drug Manufacturers company?
A good Accounts Payable & Accrued Expense depends on the Drug Manufacturers industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on MPX International and its competitors. MPX International's current Accounts Payable & Accrued Expense is $7.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current Accounts Payable & Accrued Expense of $7.74 Mil. The current Accounts Payable & Accrued Expense is $7.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For MPX International (MPXOF), the current Accounts Payable & Accrued Expense is $7.74 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPX International Business Description

Address 5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.